1008106-64-6
1008106-64-6
Chemical Structure
Lorvotuzumab mertansine
Synonym(s): IMGN-901; BB-1090
- CAS No.: 1008106-64-6
- Formula:N/A
- Molecular Weight:N/A
SMILES: [Lorvotuzumab mertansine]
Biological Activity: Lorvotuzumab mertansine is an ADC consisting of a humanized N901 monoclonal antibody against CD56 bound to maytansinoid DM1 via a stable disulfide linker. Lorvotuzumab mertansine has antitumor activity[1].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Lorvotuzumab mertansine | 99.44% | Lorvotuzumab mertansine is an ADC consisting of a humanized N901 monoclonal antibody against CD56 bound to maytansinoid DM1 via a stable disulfide linker. Lorvotuzumab mertansine has antitumor activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
